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  M
alaria remains a challenging 
prospect for researchers and 
health workers, but there is 
encouraging news to report. Malaria 
research, after many years on the 
back burner, has risen dramatically 
up the priority list of donors and 
policy makers. Much of the credit 
for this turnaround must go to the 
Multilateral Initiative on Malaria 
(MIM; http:⁄⁄www.mim.su.se). MIM’s 
achievements in the malaria world 
may indeed be a model for raising the 
proﬁ  le of other neglected health issues.
    MIM deﬁ  nes itself as “an alliance of 
organizations and individuals concerned 
with malaria.” It aims to maximize the 
impact of research on malaria in Africa, 
through promoting capacity building 
and facilitating global collaboration 
and coordination. Its key areas of focus 
include: optimizing the use of current 
drugs and developing new ones, capacity 
building in Africa, overcoming obstacles 
to vaccine development, malaria control 
and management, vector biology and 
control, the economics of malaria, 
health information systems and 
surveillance, and research methodology. 
MIMCom (http:⁄⁄www.mimcom.net) 
has provided Internet connectivity at 
20 research sites in Africa, and created 
some useful Internet resources. Other 
malaria initiatives have been launched 
in the past 10 years, and MIM has 
worked in partnership with many of 
them.
    The ﬁ  rst meeting of MIM was in 
Dakar, Senegal, in 1997. Fewer than 200 
people were present. In marked contrast, 
the fourth conference, held in Yaoundé, 
Cameroon, in November of last year, 
was attended by more than 1,500 
participants from nearly 70 countries. 
An encouraging number were young, 
enthusiastic, and African, one of whom 
won the Young Malaria Scientist of the 
Year award. The recipient, Genevieve 
Fouda Amou’ou, a Cameroonian 
working at Georgetown University 
in Washington, DC, United States, 
won the award for her work on the 
characterization of the malarial antibody 
response of Cameroonian infants. 
    There were 600 posters and 200 oral 
presentations at the meeting (see Box 
1 for crucial issues addressed). The 
conference also heard news of another 
welcome development: the MIM 
secretariat will be moving from Sweden 
to an African base, in Dar es Salaam—a 
clear reafﬁ  rmation of the organization’s 
commitment to building capacity inside 
Africa itself. Impressive global media 
coverage of the event was achieved by 
the MIM press team, further raising the 
proﬁ  le of malaria internationally. 
    Our policy at   PLoS Medicine   is to 
focus on diseases with the greatest 
global burden, and we have published 
many papers on malaria since 
our launch (see http:⁄⁄medicine.
plosjournals.org/perlserv/?request=
get-static&name=collection-malaria). 
The expansion of Internet access 
for malaria researchers has made 
open-access online publication an 
effective means of sharing the results 
of research. It is, regrettably, unlikely 
that researchers in other key health 
areas working in remote locations in 
Africa have anything like this level of 
connectivity. MIMCom could usefully 
share its experience with those working 
in other research ﬁ  elds.
    What did delegates make of their 
conference? Opinions varied on the 
quality of the research presented, and 
there were many who felt that the 
sessions describing current progress 
with international malaria programs 
merely presented information that 
was readily available elsewhere—for 
example, on the Web sites of the 
organizations concerned. Nevertheless, 
the networking opportunities afforded 
by the conference were universally 
appreciated. Sadly, there are many 
African malaria scientists who, for 
ﬁ  nancial or logistical reasons, were 
unable to attend the conference; travel 
within Africa is difﬁ  cult, and delegates 
from countries quite close to Cameroon 
found themselves obliged to ﬂ  y via 
Europe. But for those who made it, this 
was an event that, though frequently 
hectic, provided a boost for morale.
    It was, however, an event primarily   for 
researchers  . Only a minority of those 
present were involved in the treatment of 
malaria. As always, getting research into 
practice presents its own challenges.   
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  Box 1. Fourth MIM Pan-African 
Malaria Conference: The Crucial 
Issues
  •  Getting  artemisinin-based 
combination therapy (ACT) to as many 
people as possible.
    •  Finding the next generation of drugs, 
to be used when resistance to ACT 
inevitably appears.
    •  Investigating further the promising 
concept of intermittent treatment in 
childhood and pregnancy.
    •  Getting as many people as possible to 
use insecticide-treated bed nets.
    •  Improving other aspects of vector 
control: repellents, residual sprays, and 
larviciding.
    •  The RTS,S/AS02A malaria vaccine 
candidate has shown promise in early 
trials (  Lancet  364: 1411–1420). Can 
it be made into an affordable, safe, 
and effective vaccine that is quickly 
available to all those who need it?
    •  There are 24 other candidate vaccines 
awaiting clinical trials. More genomic 
research will produce further 
candidates, but some doubt that this is 
how malaria resources are best spent; 
they argue that it is more important to 
trial the candidates we already have.
    •  It is increasingly recognized that the 
nature of the malaria problem varies 
from place to place. Regional and 
local research initiatives are needed to 
develop appropriate policies.
    •  Malaria is (or at least should be) 
addressed by several interventions at 
once, but research usually evaluates 
one intervention at a time. Research 
is needed to evaluate combined 
programs.
    •  There is a pressing need for more 
research to ﬁ  nd the best ways of 
delivering effective interventions. 
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